Anaphylaxis, An Issue of Immunology and Allergy Clinics of North America, 1st Edition
In this issue of Immunology & Allergy Clinics, guest editor Dr. Marcus S. Shaker brings his considerable expertise to the topic of Anaphylaxis. Top experts provide updates on anaphylaxis epidemiology, guidelines, and diagnostics, as well as mast cell activation syndrome, mastocytosis, novel therapies, and more.
ISBNコード :
9780443416811
出版日 :
06-04-2026
In this issue of Immunology & Allergy Clinics, guest editor Dr. Marcus S. Shaker brings his considerable expertise to the topic of Anaphylaxis. Top experts provide updates on anaphylaxis epidemiology, guidelines, and diagnostics, as well as mast cell activation syndrome, mastocytosis, novel therapies, and more.
特長
- Contains 15 relevant, practice-oriented topics including venom anaphylaxis; anaphylaxis guidelines; equity and anaphylaxis; future anaphylaxis therapies; novel epinephrine delivery devices; preventing food anaphylaxis; and more
- Provides in-depth clinical reviews on anaphylaxis, offering actionable insights for clinical practice
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews
著者情報
Edited by Marcus S. Shaker, MD, Professor of Pediatrics and Medicine, Department of Allergy and Clinical Immunology Dartmouth Hitchcock Medical Center, Department of Pediatric Allergy, Dartmouth Health Children's, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA
| ISBN Number | 9780443416811 |
|---|---|
| Description Author List | Edited by Marcus S. Shaker, MD, Professor of Pediatrics and Medicine, Department of Allergy and Clinical Immunology Dartmouth Hitchcock Medical Center, Department of Pediatric Allergy, Dartmouth Health Children's, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA |
| Copyright Year | 2026 |
| Edition Number | 1 |
| Format | E-Book |
| Imprint | Elsevier |
| Page Count | 240 |
| Publication Date | 6 Apr 2026 |
| Stock Status | IN STOCK |
Anaphylaxis Epidemiology and Risk Factors
Anaphylaxis: Clinical Criteria, Severity, and Clinical Courses
Community Anaphylaxis
Equity and Anaphylaxis
Anaphylaxis Guidelines
Preventing Food Anaphylaxis
Drug Anaphylaxis
Beta-Blockers, Angiotensin-Converting Enzyme Inhibitors, and Anaphylaxis
Iodinated Contrast Media and Anaphylaxis
Venom Anaphylaxis
Novel Epinephrine Delivery Devices
Emerging Therapies for Anaphylaxis
Hereditary Alpha-Tryptasemia (HαT) as a Risk Modifier for Severe Anaphylaxis
Mast Cell Activation Syndrome and Mimickers
Anaphylaxis: Clinical Criteria, Severity, and Clinical Courses
Community Anaphylaxis
Equity and Anaphylaxis
Anaphylaxis Guidelines
Preventing Food Anaphylaxis
Drug Anaphylaxis
Beta-Blockers, Angiotensin-Converting Enzyme Inhibitors, and Anaphylaxis
Iodinated Contrast Media and Anaphylaxis
Venom Anaphylaxis
Novel Epinephrine Delivery Devices
Emerging Therapies for Anaphylaxis
Hereditary Alpha-Tryptasemia (HαT) as a Risk Modifier for Severe Anaphylaxis
Mast Cell Activation Syndrome and Mimickers
あなたのレビューを投稿する
